The TRIP13 mRNA expression level was found to be strongly associated with various clinicopathological features, including the T stage, AFP level, vascular invasion, tumor status, overall survival, and progression-free interval (PFI) events (all P < 0.05), but not with other clinicopathological factors. The gene discussed is TRIP13; the disease is neoplasm.